1. Ministry of Health, Labour and Welfare. Guideline for the quality, safety and efficacy of follow-on biological medicinal products (Notification No. 0304007); 2009. https://www.nihs.go.jp/dbcb/TEXT/yakusyokushinsahatu-0304007.pdf. Accessed June, 2019.
2. Japan Generic Medicines Association. Interim translation by JGA of Notification No. 0304007 Mar. 4, 2009 issued by Evaluation and Licensing Division, Ministry of Health, Labour and Welfare. https://www.jga.gr.jp/library/old/www.jga.gr.jp/english/wp-content/uploads/sites/4/2015/03/Interim-Translation1.pdf. Accessed June 2019.
3. Westlake WJ. Response to T.B.L. Kirkwood: bioequivalence testing—a need to rethink. Biometrics. 1981;37:589–94.
4. Schuirmann DJ. On hypothesis testing to determine if the mean of a normal distribution is contained in a known interval. Biometrics. 1981;37:617.
5. Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat Sci. 1996;11:283–319.